최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Microbial cell factories, v.20 no.1, 2021년, pp.9 -
Kim, Young Su (Department of Chemical and Biomolecular Engineering, KAIST, Daejeon, 34141 Republic of Korea) , Lee, Hye-Jeong (Biotechnology Process Engineering Center, KRIBB, Cheongju, 28116 Republic of Korea) , Han, Man-ho (Biotechnology Process Engineering Center, KRIBB, Cheongju, 28116 Republic of Korea) , Yoon, Nam-kyung (Biotechnology Process Engineering Center, KRIBB, Cheongju, 28116 Republic of Korea) , Kim, Yeu-chun (Department of Chemical and Biomolecular Engineering, KAIST, Daejeon, 34141 Republic of Korea) , Ahn, Jungoh (Biotechnology Process Engineering Center, KRIBB, Cheongju, 28116 Republic of Korea)
BackgroundGrowth factors (GFs) are signaling proteins that affect cellular processes such as growth, proliferation, and differentiation. GFs are used as cosmeceuticals, exerting anti-wrinkle, anti-aging, and whitening effects, and also as pharmaceuticals to treat wounds, growth failure, and oral muc...
1. Nguyen AN Song JA Nguyen MT Do BH Kwon GG Park SS Prokaryotic soluble expression and purification of bioactive human fibroblast growth factor 21 using maltose-binding protein Sci Rep. 2017 7 16139 10.1038/s41598-017-16167-x 29170489
2. Lee K Silva EA Mooney DJ Growth factor delivery-based tissue engineering: general approaches and a review of recent developments J R Soc Interface 2010 8 153 170 10.1098/rsif.2010.0223 20719768
3. Barrientos S Stojadinovic O Golinko MS Brem H Tomic-Canic M Growth factors and cytokines in wound healing Wound Repair Regen. 2008 16 585 601 10.1111/j.1524-475X.2008.00410.x 19128254
4. Niu Y Li Q Ding Y Dong L Wang C Engineered delivery strategies for enhanced control of growth factor activities in wound healing Adv Drug Deliv Rev 2018 146 190 208 10.1016/j.addr.2018.06.002 29879493
5. Lin WH Xiang LJ Shi HX Zhang J Jiang LP Cai PT Fibroblast growth factors stimulate hair growth through β-catenin and Shh expression in C57BL/6 mice Biomed Res Int 2015 10.1155/2015/730139 26788513
6. Hui Q Jin Z Li X Liu C Wang X FGF family: from drug development to clinical application Int J Mol Sci 2018 19 1875 10.3390/ijms19071875
7. Li J Yang Z Li Z Gu L Wang Y Sung C Exogenous IGF-1 promotes hair growth by stimulating cell proliferation and down regulating TGF-β1 in C57BL/6 mice in vivo Growth Horm IGF Res. 2014 24 89 94 10.1016/j.ghir.2014.03.004 24797500
8. Walsh G Pharmaceutical biotechnology: concepts and applications 2007 Chichester Wiley
9. Schneider BP Sledge GW Drug insight: VEGF as a therapeutic target for breast cancer Nat Clin Pract Oncol 2007 4 181 189 10.1038/ncponc0740 17327858
10. Gibbs JB Anticancer drug targets: growth factors and growth factor signaling J Clin Invest. 2000 105 9 13 10.1172/JCI9084 10619855
11. Ha JH Kim HN Moon KB Jeon JH Jung DH Kim SJ Recombinant human acidic fibroblast growth factor (aFGF) expressed in Nicotiana benthamiana potentially inhibits skin photoaging Planta Med 2017 83 862 869 10.1055/s-0043-103964 28249301
12. Yang J Guan L Guo Y Du L Wang F Wang Y Expression of biologically recombinant human acidic fibroblast growth factor in Arabidopsis thaliana seeds via oleosin fusion technology Gene 2015 566 89 94 10.1016/j.gene.2015.04.036 25889272
13. eraska J Pasikowska M Szczepanik B Mlosek K Malinowska S Dbowska RM A study of the activity and effectiveness of recombinant fibroblast growth factor (Q40P/S47I/H93G rFGF-1) in anti-aging treatment Postepy Dermatol Alergol. 2016 33 28 36 10.5114/pdia.2014.44024 26985176
14. Choi SW Pangeni R Jung DH Kim SJ Park JW Construction and characterization of cell-penetrating peptide-fused fibroblast growth factor and vascular endothelial growth factor for an enhanced percutaneous delivery system J Nanosci Nanotechnol 2018 18 842 847 10.1166/jnn.2018.14864 29448503
15. Kumagai Y Kikuchi T Nonaka A Hiraide M Sato S Sakuraoka M Site-directed mutagenesis of cysteine to serine residues affects heparin binding and mitogenicity in fibroblast growth factor 4 produced in Escherichia coli Biotechnol Equip. 2019 33 498 503 10.1080/13102818.2019.1590161
16. Taktak-BenAmar A Morjen M Mabrouk HB Abdelmaksoud-Dammak R Guerfali M Fourati-Masmoudi N Expression, purification and functionality of bioactive recombinant human vascular endothelial growth factor VEGF 165 in E. coli AMB Express. 2017 7 33 10.1186/s13568-016-0300-2 28168572
17. Nguyen MT Krupa M Koo B-K Song J-A Vu TTT Do BH Prokaryotic soluble overexpression and purification of human VEGF165 by fusion to a maltose binding protein tag PLoS ONE 2016 11 e0156296 10.1371/journal.pone.0156296 27231876
18. Sun C Li Y Taylor SE Mao X Wilkinson MC Fernig DG HaloTag is an effective expression and solubilisation fusion partner for a range of fibroblast growth factors PeerJ. 2015 10.7717/peerj.1060 26719820
19. Nasiri M Babaie J Amiri S Azimi E Shamshiri S Khalaj V SHuffle™ T7 strain is capable of producing high amount of recombinant human fibroblast growth factor-1 (rhFGF-1) with proper physicochemical and biological properties J Biotechnol 2017 259 30 38 10.1016/j.jbiotec.2017.08.015 28827102
20. Li D Fu G Tu R Jin Z Zhang D High-efficiency expression and secretion of human FGF21 in Bacillus subtilis by intercalation of a mini-cistron cassette and combinatorial optimization of cell regulatory components Microb Cell Fact 2019 18 17 10.1186/s12934-019-1066-4 30691455
21. Blaimauer K Watzinger E Erovic BM Martinek H Jagersberger T Thurnher D Effects of epidermal growth factor and keratinocyte growth factor on the growth of oropharyngeal keratinocytes in coculture with autologous fibroblasts in a three-dimensional matrix Cells Tissues Organs. 2006 182 98 105 10.1159/000093064 16804300
22. Mohseni N Jahanian-Najafabadi A Kazemi-Lomedasht F Arezomand R Habibi-Anbouhi M Shahbazzadeh D Recombinant expression and purification of functional vascular endothelial growth factor-121 in the baculovirus expression system Asian Pac J Trop Med. 2016 9 1195 1199 10.1016/j.apjtm.2016.09.012 27955747
23. Wu X Yin Z Cao C Huang L Lu X Liu J Expression of human VEGF165 in silkworm ( Bombyx mori L.) by using a recombinant baculovirus and its bioactivity assay J Biotechnol. 2004 111 253 261 10.1016/j.jbiotec.2004.04.016 15246661
24. Wang F Wang R Wang Y Zhao P Xia Q Large-scale production of bioactive recombinant human acidic fibroblast growth factor in transgenic silkworm cocoons Sci Rep. 2015 5 16323 10.1038/srep16323 26567460
25. Rosano GL Ceccarelli EA Recombinant protein expression in Escherichia coli : advances and challenges Front Microbiol. 2014 5 172 10.3389/fmicb.2014.00172 24860555
26. Berkmen M Production of disulfide-bonded proteins in Escherichia coli Protein Expr Purif 2012 82 240 251 10.1016/j.pep.2011.10.009 22085722
27. Ke N Berkmen M Production of disulfide-bonded proteins in Escherichia coli Curr Protoc Mol Biol. 2014 10.1002/0471142727.mb1601bs108 25271713
28. Lobstein J Emrich CA Jeans C Faulkner M Riggs P Berkmen M SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm Microb Cell Fact 2012 11 753 10.1186/1475-2859-11-56
29. Zhao Q Xu W Xing L Lin Z Recombinant production of medium-to large-sized peptides in Escherichia coli using a cleavable self-aggregating tag Microb Cell Fact 2016 15 136 10.1186/s12934-016-0534-3 27495238
30. Kaplan O Zarubova J Mikulova B Filova E Bartova J Baakova L Enhanced mitogenic activity of recombinant human vascular endothelial growth factor VEGF121 expressed in E. coli origami B (DE3) with molecular chaperones PLoS ONE 2016 11 e0163697 10.1371/journal.pone.0163697 27716773
31. Ki MR Pack SP Fusion tags to enhance heterologous protein expression Appl Microbiol Biotechnol 2020 104 2411 2425 10.1007/s00253-020-10402-8 31993706
32. Costa SJ Almeida A Castro A Domingues L Besir H The novel Fh8 and H fusion partners for soluble protein expression in Escherichia coli : a comparison with the traditional gene fusion technology Appl Microbiol Biotechnol 2013 97 6779 6791 10.1007/s00253-012-4559-1 23160981
33. Silva E Castro A Lopes A Rodrigues A Dias C Conceicao A A recombinant antigen recognized by Fasciola hepatica -infected hosts J Parasitol 2014 90 746 751 10.1645/GE-136R
34. Fraga H Faria TQ Pinto F Almeida A Brito RM Damas AM FH8?a small EF-hand protein from Fasciola hepatica FEBS J 2010 277 5072 5085 10.1111/j.1742-4658.2010.07912.x 21078120
35. Costa S Almeida A Castro A Domingues L Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli : the novel Fh8 system Front Microbiol. 2014 5 63 10.3389/fmicb.2014.00063 24600443
36. Kim YS Karisa N Jeon WY Lee H Kim YC Ahn J High-level production of N-terminal pro-brain natriuretic peptide, as a calibrant of heart failure diagnosis, in Escherichia coli Appl Microbiol Biotechnol 2019 103 4779 4788 10.1007/s00253-019-09826-8 31041470
37. Sun C Liang J Shi R Gao X Zhang R Hong F Tobacco etch virus protease retains its activity in various buffers and in the presence of diverse additives Protein Expr Purif 2012 82 226 231 10.1016/j.pep.2012.01.005 22285121
38. Holmes DI Zachary I The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease Genome Biol 2005 6 209 10.1186/gb-2005-6-2-209 15693956
40. Kapust RB Tozser J Copeland TD Waugh DS The P1′ specificity of tobacco etch virus protease Biochem Biophys Res Commun 2002 294 949 955 10.1016/S0006-291X(02)00574-0 12074568
41. Sequeira AF Turchetto J Saez NJ Peysson F Ramond L Duhoo Y Gene design, fusion technology and TEV cleavage conditions influence the purification of oxidized disulphide-rich venom peptides in Escherichia coli Microb Cell Fact 2017 16 1 16 10.1186/s12934-016-0618-0 28049473
42. Markert Y Koditz J Ulbrich-Hofmann R Arnold U Proline versus charge concept for protein stabilization against proteolytic attack Protein Eng 2003 16 1041 1046 10.1093/protein/gzg136 14983085
43. Waugh DS An overview of enzymatic reagents for the removal of affinity tags Protein Expr Purif 2011 80 283 293 10.1016/j.pep.2011.08.005 21871965
44. Pesarrodona M Unzueta U Vazquez E Clifton NJ Dialysis: a characterization method of aggregation tendency Methods in Molecular Biology 2015 New York Humana Press 321 330
45. Lebendiker M Danieli T Production of prone-to-aggregate proteins FEBS Lett 2014 588 236 246 10.1016/j.febslet.2013.10.044 24211444
46. Kumar CS Swamy MJ Differential modulation of the chaperone-like activity of HSP-1/2, a major protein of horse seminal plasma by anionic and cationic surfactants Int J Biol Macromol 2017 96 524 531 10.1016/j.ijbiomac.2016.12.053 28013009
47. Banga AK Therapeutic peptides and proteins: formulation, processing, and delivery systems 2015 3 Boca Raton CRC Press
48. Bondos SE Bicknell A Detection and prevention of protein aggregation before, during, and after purification Anal Biochem 2003 316 223 231 10.1016/s0003-2697(03)00059-9 12711344
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.